{"id":"https://openalex.org/W3083339019","doi":"https://doi.org/10.1158/1538-7445.am2020-5531","title":"Abstract 5531: K0401-020 anti-VISTA antibody monotherapy increases specific CD8 T cell response in non-human primates","display_name":"Abstract 5531: K0401-020 anti-VISTA antibody monotherapy increases specific CD8 T cell response in non-human primates","alternate_titles":[],"publication_year":2020,"publication_date":"2020-08-15","ids":{"openalex":"https://openalex.org/W3083339019","doi":"https://doi.org/10.1158/1538-7445.am2020-5531","mag":"3083339019"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2020-5531","doi":"https://doi.org/10.1158/1538-7445.am2020-5531","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-5531","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3083339019"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080298564","display_name":"Christine Libon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christine Libon","raw_affiliation_strings":["1Pierre Fabre Research Institute, Toulouse, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Pierre Fabre Research Institute, Toulouse, France;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055186435","display_name":"Isabelle Vandenberghe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Isabelle Vandenberghe","raw_affiliation_strings":["1Pierre Fabre Research Institute, Toulouse, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Pierre Fabre Research Institute, Toulouse, France;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037631225","display_name":"Romain Marlin","orcid":"https://orcid.org/0000-0001-8932-0171","observed_orcids":["https://orcid.org/0000-0001-8932-0171"]},"institutions":[{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]},{"id":"https://openalex.org/I4210097138","display_name":"CEA Paris-Saclay - Etablissement de Fontenay-aux-roses","ror":"https://ror.org/010j2gw05","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210097138","https://openalex.org/I4210128565"]},{"id":"https://openalex.org/I4210128767","display_name":"Infectious Disease Models and Innovative Therapies","ror":"https://ror.org/03bk36k19","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210128767"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Romain Marlin","raw_affiliation_strings":["2CEA - IDMIT/ImVA Research Institute, Fontenay-aux-Roses, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2CEA - IDMIT/ImVA Research Institute, Fontenay-aux-Roses, France","institution_ids":["https://openalex.org/I2738703131","https://openalex.org/I4210097138","https://openalex.org/I4210128767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080501412","display_name":"Wesley Gros","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]},{"id":"https://openalex.org/I4210097138","display_name":"CEA Paris-Saclay - Etablissement de Fontenay-aux-roses","ror":"https://ror.org/010j2gw05","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210097138","https://openalex.org/I4210128565"]},{"id":"https://openalex.org/I4210128767","display_name":"Infectious Disease Models and Innovative Therapies","ror":"https://ror.org/03bk36k19","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210128767"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Wesley Gros","raw_affiliation_strings":["2CEA - IDMIT/ImVA Research Institute, Fontenay-aux-Roses, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2CEA - IDMIT/ImVA Research Institute, Fontenay-aux-Roses, France","institution_ids":["https://openalex.org/I2738703131","https://openalex.org/I4210097138","https://openalex.org/I4210128767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015917961","display_name":"Marco L\u00e9onec","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]},{"id":"https://openalex.org/I4210097138","display_name":"CEA Paris-Saclay - Etablissement de Fontenay-aux-roses","ror":"https://ror.org/010j2gw05","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210097138","https://openalex.org/I4210128565"]},{"id":"https://openalex.org/I4210128767","display_name":"Infectious Disease Models and Innovative Therapies","ror":"https://ror.org/03bk36k19","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210128767"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marco Leonec","raw_affiliation_strings":["2CEA - IDMIT/ImVA Research Institute, Fontenay-aux-Roses, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2CEA - IDMIT/ImVA Research Institute, Fontenay-aux-Roses, France","institution_ids":["https://openalex.org/I2738703131","https://openalex.org/I4210097138","https://openalex.org/I4210128767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083964721","display_name":"Mario Gomez-Pacheco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]},{"id":"https://openalex.org/I4210097138","display_name":"CEA Paris-Saclay - Etablissement de Fontenay-aux-roses","ror":"https://ror.org/010j2gw05","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210097138","https://openalex.org/I4210128565"]},{"id":"https://openalex.org/I4210128767","display_name":"Infectious Disease Models and Innovative Therapies","ror":"https://ror.org/03bk36k19","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210128767"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Mario Gomez-Pacheco","raw_affiliation_strings":["2CEA - IDMIT/ImVA Research Institute, Fontenay-aux-Roses, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2CEA - IDMIT/ImVA Research Institute, Fontenay-aux-Roses, France","institution_ids":["https://openalex.org/I2738703131","https://openalex.org/I4210097138","https://openalex.org/I4210128767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006966237","display_name":"Anne-Sophie Gallou\u00ebt","orcid":"https://orcid.org/0000-0001-5815-3454","observed_orcids":["https://orcid.org/0000-0001-5815-3454"]},"institutions":[{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]},{"id":"https://openalex.org/I4210097138","display_name":"CEA Paris-Saclay - Etablissement de Fontenay-aux-roses","ror":"https://ror.org/010j2gw05","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210097138","https://openalex.org/I4210128565"]},{"id":"https://openalex.org/I4210128767","display_name":"Infectious Disease Models and Innovative Therapies","ror":"https://ror.org/03bk36k19","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210128767"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Anne-Sophie Gallouet","raw_affiliation_strings":["2CEA - IDMIT/ImVA Research Institute, Fontenay-aux-Roses, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2CEA - IDMIT/ImVA Research Institute, Fontenay-aux-Roses, France","institution_ids":["https://openalex.org/I2738703131","https://openalex.org/I4210097138","https://openalex.org/I4210128767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003582346","display_name":"Fran\u00e7oise Fraboul","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fran\u00e7oise Fraboul","raw_affiliation_strings":["1Pierre Fabre Research Institute, Toulouse, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Pierre Fabre Research Institute, Toulouse, France;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063024355","display_name":"Abderrahim Mahfoudi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abderrahim Mahfoudi","raw_affiliation_strings":["1Pierre Fabre Research Institute, Toulouse, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Pierre Fabre Research Institute, Toulouse, France;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007314757","display_name":"Nathalie Dereuddre\u2010Bosquet","orcid":"https://orcid.org/0000-0001-6682-6313","observed_orcids":["https://orcid.org/0000-0001-6682-6313"]},"institutions":[{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]},{"id":"https://openalex.org/I4210097138","display_name":"CEA Paris-Saclay - Etablissement de Fontenay-aux-roses","ror":"https://ror.org/010j2gw05","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210097138","https://openalex.org/I4210128565"]},{"id":"https://openalex.org/I4210128767","display_name":"Infectious Disease Models and Innovative Therapies","ror":"https://ror.org/03bk36k19","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210128767"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nathalie Dereuddre-Bosquet","raw_affiliation_strings":["2CEA - IDMIT/ImVA Research Institute, Fontenay-aux-Roses, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2CEA - IDMIT/ImVA Research Institute, Fontenay-aux-Roses, France","institution_ids":["https://openalex.org/I2738703131","https://openalex.org/I4210097138","https://openalex.org/I4210128767"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006952731","display_name":"Pierre J. Ferr\u00e9","orcid":"https://orcid.org/0009-0009-5125-1153","observed_orcids":["https://orcid.org/0009-0009-5125-1153"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pierre Ferr\u00e9","raw_affiliation_strings":["1Pierre Fabre Research Institute, Toulouse, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Pierre Fabre Research Institute, Toulouse, France;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"16_Supplement","first_page":"5531","last_page":"5531"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8485999703407288,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8485999703407288,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.10220000147819519,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.031300000846385956,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vista","display_name":"VISTA","score":0.9409999847412109},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7699999809265137},{"id":"https://openalex.org/keywords/cd8-t-cell-responses","display_name":"CD8+ T cell responses","score":0.9549999833106995},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.8600000143051147},{"id":"https://openalex.org/keywords/anti-pd-1-antibody","display_name":"anti-PD-1","score":0.722000002861023},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.5090000033378601},{"id":"https://openalex.org/keywords/nonhuman-primates","display_name":"non-human primates","score":0.6919999718666077},{"id":"https://openalex.org/keywords/cynomolgus-macaques","display_name":"cynomolgus macaques","score":0.9729999899864197},{"id":"https://openalex.org/keywords/dendritic-cell-activation","display_name":"dendritic cell activation","score":0.5820000171661377},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.5600000023841858}],"concepts":[{"id":"https://openalex.org/C2779909307","wikidata":"https://www.wikidata.org/wiki/Q1660181","display_name":"Immunogen","level":4,"score":0.6295791268348694},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6209356784820557},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.603269636631012},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5599532723426819},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5521772503852844},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5378438830375671},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5357254147529602},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.515591561794281},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4364444613456726},{"id":"https://openalex.org/C2780801004","wikidata":"https://www.wikidata.org/wiki/Q1415366","display_name":"Immunization","level":3,"score":0.4262257218360901},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.23804247379302979},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.18809723854064941},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2020-5531","doi":"https://doi.org/10.1158/1538-7445.am2020-5531","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-5531","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389480707","https://openalex.org/W4244647167","https://openalex.org/W4389626311","https://openalex.org/W3126611317","https://openalex.org/W3212472921","https://openalex.org/W3105816697","https://openalex.org/W3178473295","https://openalex.org/W4282944481","https://openalex.org/W3111007297","https://openalex.org/W4308376715"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"VISTA":[2],"is":[3,25,123,142],"a":[4,10,26,110,152,157,181,226,328,356],"B7":[5],"family":[6],"protein":[7],"described":[8,143],"as":[9,109,144,280,282,355],"negative":[11],"checkpoint":[12],"of":[13,76,94,115,137,167,175,197,201,211,230,250,416,420],"T":[14,50,81,99,116,340,363,407],"cell":[15,51,62,100,117,264,341,364,408],"responses,":[16],"both":[17],"in":[18,55,73,103,126,134,147,247,287,301,314,334,410],"autoimmunity":[19],"and":[20,45,155,160,263,274,305,316,373,431],"cancer":[21],"murine":[22],"models.":[23,88],"K01401-020":[24,40,58,353],"novel":[27],"IND":[28],"enabling":[29],"anti-VISTA":[30,77,95,237,306,330,351,401],"antibody.":[31],"In":[32,53],"vitro,":[33],"when":[34],"incubated":[35],"with":[36,209,217],"human":[37],"blood":[38],"cells,":[39,43],"stimulates":[41],"NK":[42],"monocytes":[44],"cytokine":[46],"production,":[47],"contributing":[48],"to":[49,193],"activation.":[52],"vivo,":[54],"non-human":[56,104,335,411],"primates,":[57,105],"notably":[59],"induced":[60],"dendritic":[61],"activation":[63,102],"(Loukili":[64],"et":[65,187],"al,":[66,188],"AACR":[67],"2019).":[68],"However,":[69],"so":[70],"far,":[71],"no":[72],"vivo":[74],"demonstration":[75],"pharmacodynamic":[78,165],"effect":[79,93],"on":[80,97,245,269],"cells":[82],"has":[83],"been":[84],"demonstrated":[85],"beyond":[86],"mouse":[87],"Thus,":[89],"we":[90,171,321],"explored":[91,172],"the":[92,135,164,195,221,248,284,324,417,421],"antibody":[96,234,238,307,331,352,402],"CD8":[98,158,185,276,310,339,362,406],"specific":[101,311,338,405],"using":[106],"SIV":[107],"immunization":[108,177,286,297],"model.":[111],"Methods:":[112],"The":[113,295,346],"detection":[114],"response":[118,183,409],"amplification":[119],"by":[120,214],"immune-checkpoint":[121,168],"inhibitors":[122],"very":[124],"challenging":[125],"primates":[127,336,412],"during":[128],"standard":[129],"PK":[130],"or":[131,236,255],"safety":[132],"studies":[133],"absence":[136],"adequate":[138],"antigen":[139],"stimulation.":[140],"KLH":[141],"an":[145],"immunogen":[146],"monkeys":[148],"but":[149],"induces":[150,179],"mainly":[151],"humoral":[153],"(IgG/IgM)":[154],"not":[156],"response,":[159],"thus":[161],"cannot":[162],"reveal":[163,194],"activity":[166,196,365],"inhibitors.":[169,199],"Here,":[170],"well-described":[173],"model":[174],"primate":[176],"that":[178,327,350],"specifically":[180],"cellular":[182],"including":[184],"(Martinon":[186],"Hum":[189],"Gene":[190],"Ther.":[191],"2009)":[192],"Immune-checkpoints":[198],"Groups":[200],"three":[202],"adult":[203],"cynomolgus":[204],"macaques":[205],"were":[206,267,278],"immunized":[207],"thrice":[208],"1mg":[210],"MultiSIVmac239":[212],"GTU-DNA,":[213],"intradermal":[215],"route":[216],"electroporation.":[218],"One-day":[219],"after":[220,283],"last":[222],"immunization,":[223],"animals":[224,291],"received":[225],"single":[227,329,357],"intravenous":[228],"injection":[229],"either":[231,251],"vehicle,":[232],"anti-PD1":[233],"(pembrolizumab)":[235],"K01401-020.":[239],"IFN\u03b3":[240],"ELISPOT":[241],"assay":[242,262],"was":[243],"performed":[244,268],"PBMCs":[246],"presence":[249],"Nef":[252],"RM9":[253,260,273],"peptide":[254],"Gag":[256],"(peptide":[257],"pool),":[258],"while":[259],"tetramer":[261],"subsets":[265],"phenotyping":[266],"whole":[270],"blood.":[271],"Results:":[272],"gag-specific":[275],"responses":[277,300,312,342],"evidenced":[279],"soon":[281],"second":[285],"at":[288],"least":[289],"2/3":[290,315],"from":[292],"all":[293,302],"groups.":[294,303],"third":[296],"reactivated":[298],"CD8-specific":[299],"Pembrolizumab":[304],"clearly":[308],"amplified":[309],"respectively":[313],"3/3":[317],"monkeys.":[318],"Conclusions:":[319],"Here":[320],"show":[322],"for":[323,424],"first":[325],"time":[326],"infusion":[332],"monotherapy":[333,403],"potentializes":[337],"against":[343,366],"exogenous":[344],"antigen.":[345],"above":[347],"data":[348],"suggests":[349],"given":[354],"agent":[358],"may":[359],"effectively":[360],"boosts":[361],"tumor":[367],"antigens.":[368],"Confidential":[369],"\u2013":[370],"Pierre":[371,398],"Fabre":[372],"CEA":[374],"collaboration":[375],"Citation":[376],"Format:":[377],"Christine":[378],"Libon,":[379],"Isabelle":[380],"Vandenberghe,":[381],"Romain":[382],"Marlin,":[383],"Wesley":[384],"Gros,":[385],"Marco":[386],"Leonec,":[387],"Mario":[388],"Gomez-Pacheco,":[389],"Anne-Sophie":[390],"Gallouet,":[391],"Fran\u00e7oise":[392],"Fraboul,":[393],"Abderrahim":[394],"Mahfoudi,":[395],"Nathalie":[396],"Dereuddre-Bosquet,":[397],"Ferr\u00e9.":[399],"K0401-020":[400],"increases":[404],"[abstract].":[413],"In:":[414],"Proceedings":[415],"Annual":[418],"Meeting":[419],"American":[422],"Association":[423],"Cancer":[425,437],"Research":[426],"2020;":[427],"2020":[428],"Apr":[429],"27-28":[430],"Jun":[432],"22-24.":[433],"Philadelphia":[434],"(PA):":[435],"AACR;":[436],"Res":[438],"2020;80(16":[439],"Suppl):Abstract":[440],"nr":[441],"5531.":[442]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3083339019","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2020-09-11T00:00:00"}
